Skip to main content

Atorvastatin Dosage

Medically reviewed by Drugs.com. Last updated on Jun 22, 2023.

Applies to the following strengths: 10 mg; 20 mg; 40 mg; 80 mg; 20 mg/5 mL

Usual Adult Dose for Prevention of Cardiovascular Disease

Starting dose: 10 to 20 mg orally once a day
Maintenance dose: 10 to 80 mg orally once a day

Uses: To reduce the risk of:

Usual Adult Dose for Homozygous Familial Hypercholesterolemia

Starting dose: 10 to 20 mg orally once a day
Maintenance dose: 10 to 80 mg orally once a day

Comments:


Use: As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in patients with homozygous familial hypercholesterolemia (HoFH)

Usual Adult Dose for Hyperlipidemia

Starting dose: 10 to 20 mg orally once a day
Maintenance dose: 10 to 80 mg orally once a day

Comments:


Uses: As an adjunct to diet:

Usual Adult Dose for Hyperlipoproteinemia Type III (Elevated beta-VLDL + IDL)

Starting dose: 10 to 20 mg orally once a day
Maintenance dose: 10 to 80 mg orally once a day

Comments:


Uses: As an adjunct to diet:

Usual Adult Dose for Hypertriglyceridemia

Starting dose: 10 to 20 mg orally once a day
Maintenance dose: 10 to 80 mg orally once a day

Comments:


Uses: As an adjunct to diet:

Usual Adult Dose for Heterozygous Familial Hypercholesterolemia

Starting dose: 10 to 20 mg orally once a day
Maintenance dose: 10 to 80 mg orally once a day

Comments:


Uses: As an adjunct to diet:

Usual Pediatric Dose for Heterozygous Familial Hypercholesterolemia

10 years and older:


Use: As an adjunct to diet to reduce LDL-C in patients with HeFH

Usual Pediatric Dose for Homozygous Familial Hypercholesterolemia

10 years and older:


Use: As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in patients with HoFH

Renal Dose Adjustments

Renal dysfunction: No adjustment recommended

Comments:

Liver Dose Adjustments

Acute liver failure or decompensated cirrhosis: Contraindicated

Dose Adjustments

Assess LDL-C when clinically appropriate (as early as 4 weeks after starting this drug) and adjust the dosage if needed.

Coadministration with the following drugs requires dosage modification of this drug:


The manufacturer product information should be consulted for additional recommendations regarding coadministration of this drug with other antiviral agents, azole antifungals, or macrolide antibiotics.

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 10 years with HeFH or HoFH.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Comments:

Other Comments

Administration advice:


Storage requirements:

General:

Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.